Are there ovarian carcinoma clinical trials in New York?

Yes. We're currently tracking 51 recruiting ovarian carcinoma studies with a site in New York, each rewritten in plain language so you can see what it's testing and who it's for.

How do I find out if I qualify for a ovarian carcinoma study in New York?

Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.

Do I have to live in New York to take part?

Not necessarily. These studies have a site in New York, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.

Does it cost anything to join a ovarian carcinoma trial?

Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.

Clinical trials · New York

Ovarian Carcinoma clinical trials in New York

We’re tracking 51 recruiting ovarian carcinoma studies with a site in New York — including Phase 1/Phase 2 studies, each written for real people, not researchers.

Recruiting studies in New York

NCT04657068RecruitingPhase 1/Phase 2
Study of ART0380 for advanced solid tumors
This study tests a new drug called ART0380 for people with advanced solid tumors that have not responded to standard treatments. It may be especially helpful for those with certain DNA repair gene changes (like ATM or BRCA). The drug will be given alone or with chemotherapy (gemcitabine or irinotecan) depending on the part of the trial.
East Syracuse, New YorkAges 18 years+
NCT05334069Recruiting
Blood test study for early cancer detection in patients
This study collects blood from people with cancer and people without cancer (or with possible cancer) to test whether new blood tests can detect cancer earlier. Your blood samples help researchers evaluate how well these tests work.
Jamaica, New YorkAges 40–75
NCT04585750RecruitingPhase 1/Phase 2
Studying a new drug for cancers with a specific TP53 change
This trial tests a new drug (rezatapopt) for people with advanced cancers that have a specific change in the TP53 gene, called Y220C. The drug is designed to target this change and may slow or stop cancer growth. Some participants may also receive an immunotherapy drug called pembrolizumab (Keytruda).
New York, New YorkAges 12 years+

Ovarian Carcinoma trials by city in New York

Where these studies are running in New York

Institutions with a site for the recruiting ovarian carcinoma studies listed above.

Columbia University Irving Medical Center · 2 studies
Arnot Ogden Medical Center
Elmhurst Hospital Center
Glens Falls Hospital
Hematology Oncology Associates of Central New York
Memorial Sloan Kettering Cancer Center
Northwell Health
Queens Hospital Center

What taking part in a ovarian carcinoma study involves

A screening visit first

Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.

Care at a nearby site

Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.

You stay in control

Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.

The team decides eligibility

Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.

Ovarian Carcinoma trials in other states

Common questions

Are there ovarian carcinoma clinical trials in New York?: Yes. We're currently tracking 51 recruiting ovarian carcinoma studies with a site in New York, each rewritten in plain language so you can see what it's testing and who it's for.
How do I find out if I qualify for a ovarian carcinoma study in New York?: Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
Do I have to live in New York to take part?: Not necessarily. These studies have a site in New York, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
Does it cost anything to join a ovarian carcinoma trial?: Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.

Not the right time?

New ovarian carcinoma studies open in New York regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.

Get told when a study that fits you opens

Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.